CompanyGraph
Guangzhou LBP Medicine Science & Technology Co., Ltd.
688393 · SSE · China
gzlbp.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $38.44M, above the global median of $16.24M
- PositionDebt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.49%Below 5Y avg (0.76%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
750.0%High
Last Ex-Dividend
Jun 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.90BCNY281.91M · vs all stocks (USD)
Revenue (TTM)
351.45MCNY52.26M · vs all stocks (USD)
Profit Margin
-10.75%vs Medical Instruments & Supplies peers
Beta
0.4660xvs all stocks
52-Week Change
-36.49%vs all stocks
Market Capitalization
1.90BCNY281.91M · vs all stocks (USD)
Enterprise Value
1.51BCNY223.82M · vs all stocks (USD)
Price to Sales (TTM)
5.53xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.65xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.28xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-101.28xvs Medical Instruments & Supplies peers
Gross Margin
67.23%vs Medical Instruments & Supplies peers
Profit Margin
-10.75%vs Medical Instruments & Supplies peers
Operating Margin
-5.11%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-2.63%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-3.39%vs Medical Instruments & Supplies peers
Revenue (TTM)
351.45MCNY52.26M · vs all stocks (USD)
Revenue per Share (TTM)
3.74CNYUpdated Aug 21, 2026Quarterly Revenue Growth
9.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
221.52MCNY32.94M · vs all stocks (USD)
EBITDA (TTM)
6.44MCNY958.15K · vs all stocks (USD)
Net Income (TTM)
-37.79MCNY-5.62M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-32.65%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
17.31MCNY2.57M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
258.49MCNY38.44M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.49%vs all stocks
5-Year Average Dividend Yield
0.76%vs all stocks
Payout Ratio
750.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
-24.53MCNYFY2025 · Dec 31, 2025Revenue
344.45MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
125.22MCNYFY2025 · Dec 31, 2025Gross Profit
219.22MCNYFY2025 · Dec 31, 2025Operating Income
-54.58MCNY-8.12M · vs all stocks (USD)
Pre-tax Income
-55.16MCNYFY2025 · Dec 31, 2025Income Tax Expense
-4.36MCNYFY2025 · Dec 31, 2025Net Income
-50.80MCNYFY2025 · Dec 31, 2025EBIT
-54.84MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
6.44MCNYFY2025 · Dec 31, 2025Research & Development
36.06MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
93.31MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.11MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.79MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
327.03KCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.5000CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.5000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
94.05MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
94.05MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-50.80MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.78MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-1.88MCNYFY2025 · Dec 31, 2025Free Cash Flow
-25.03MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
31.26MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-50.80MCNYFY2025 · Dec 31, 2025Other Non-cash Items
4.78MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
69.18MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-25.04MCNYFY2025 · Dec 31, 2025Capital Expenditures
-23.15MCNYFY2025 · Dec 31, 2025Net Acquisitions
-7.13MCNYFY2025 · Dec 31, 2025Purchase of Investments
-786.75MCNYFY2025 · Dec 31, 2025Sale of Investments
742.44MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-74.58MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
150.00KCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-7.30MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-9.53MCNYFY2025 · Dec 31, 2025Other Financing Charges
-9.14MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-25.82MCNYFY2025 · Dec 31, 2025Shares Outstanding
93.57MSharesUpdated Aug 21, 2026Float Shares
55.12MSharesUpdated Aug 21, 2026% Held by Insiders
48.40%vs all stocks
% Held by Institutions
3.99%vs all stocks
Total Cash (MRQ)
300.24MCNY44.65M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.21CNYUpdated Aug 21, 2026Total Debt (MRQ)
2.73MCNY405.59K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0024xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
9.43xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
12.63CNYUpdated Aug 21, 2026Total Assets
1.29BCNY191.45M · vs all stocks (USD)
Total Current Assets
612.13MCNYFY2025 · Dec 31, 2025Total Liabilities
127.98MCNYFY2025 · Dec 31, 2025Total Non-current Assets
675.28MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
44.61MCNYFY2025 · Dec 31, 2025Total Current Liabilities
83.37MCNYFY2025 · Dec 31, 2025Cash
31.18MCNYFY2025 · Dec 31, 2025Cash Equivalents
89.67KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
31.27MCNYFY2025 · Dec 31, 2025Other Short-term Investments
234.36MCNYFY2025 · Dec 31, 2025Accounts Receivable
176.82MCNYFY2025 · Dec 31, 2025Inventory
90.12MCNYFY2025 · Dec 31, 2025Accounts Payable
33.73MCNYFY2025 · Dec 31, 2025Short-term Debt
2.22MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.04MCNYFY2025 · Dec 31, 2025Long-term Debt
879.45KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.65MCNYFY2025 · Dec 31, 2025Common Stock (Book)
93.57MCNYFY2025 · Dec 31, 2025Retained Earnings
324.99MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.16BCNY172.42M · vs all stocks (USD)
52-Week Low
15.70CNYUpdated Aug 21, 202652-Week High
38.96CNYUpdated Aug 21, 202652-Week Change
-36.49%vs all stocks
Beta
0.4660xvs all stocks
50-Day MA
18.57CNYUpdated Aug 21, 2026200-Day MA
23.52CNYUpdated Aug 21, 2026Avg 10-Day Volume
2.03MSharesUpdated Aug 21, 2026Avg 30-Day Volume
2.07MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-0.4000CNYUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
Where is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 65.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.67Profit Margin: -0.11
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.60
Altman Z-Score 9.86: safe zoneNotable
Altman Z-Score: 9.86
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $38.44M, above the global median of $16.24MNotable
Levered free cash flow (USD): 38,439,681.479Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Spcg Public Company Limited
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Young Optics Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shanghai Sanmao Enterprise Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Southeast Cement Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Nagano Keiki Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shanghai Rendu Biotechnology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Zhejiang Yayi Metal Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tristel Plc
Tier 1ProductionThroughput-Bound ConversionRule
NOCIL Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Airjoule Technologies Corp.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Nanjing Xinjiekou Department Store Co. Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityDown-Close Share With Multi-Year Earnings Decrease
Wuhan Easydiagnosis Biomedicine Co., Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityDown-Close Share With Multi-Year Earnings Decrease
Hebei Sinopack Electronic Co., Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityPartial Recovery After Sharp Decline